Other medication classes used in diabetes

Type 2 diabetes and polyvascular disease are additive risk factors for cardiovascular events in patients with acute coronary syndromes, a secondary analysis of the IMPROVE-IT trial suggests.

Advisory Board member Clipper Young recounts an experience of starting a patient with erectile dysfunction on the path to appropriate treatment for him and his diabetes [read more].

Get more on: Diabetic complications | Psychosocial care | View from the clinic

Nephrologist and Endocrinologist Katherine Tuttle joins Primary Care Physician Jay Shubrook to discuss the importance of kidney disease screening for the prevention of downstream nephropathy and cardiovascular disease in patients with diabetes [watch the video 8:16].

Get more on: Nephropathy | Diabetes complications and comorbidities

This review will evaluate mechanisms responsible for chronic kidney disease-induced insulin resistance and therapies currently available [read more].
Dave N, Wu J, Thomas S. Curr Diab Rep 2018; 18: 44. doi: 10.1007/s11892-018-1010-8

Get more on:  Diabetic complications | Type 1 diabetes | Type 2 diabetes

Modestly increasing glucagon levels when commencing physical activity could be an effective strategy for preventing exercise-induced hypoglycemia among patients with type 1 diabetes, results of a randomized crossover trial suggest.

A systematic review and meta-analysis of randomized controlled trials was conducted to quantitatively synthesize existing scientific evidence on the glycemic impact of non-nutritive sweeteners [read more].
Nichol AD, Holle MJ, An R. Eur J Clin Nutr 2018. doi: 10.1038/s41430-018-0170-6

Get more on: Type 2 diabetes | Glycemic control | Diet and nutritional management

We estimate the risk of developing long-term major cardiovascular and renal complications in relation to levels of body mass index in a population of White European, African-Caribbean, and South Asian patients with type 2 diabetes mellitus [read more].
Owusu Adjah ES et al. Cardiovasc Diabetol 2018; 17: 70. doi: 10.1186/s12933-018-0712-1

Get more on: Type 2 diabetes | Diabetes in specific populations | Diabetic complications

In the wake of the revised blood pressure targets, Editorial Board member Jay Shubrook and Advisory Board member Robert Chilton discuss clinical approaches to get hypertensive diabetes patients to target more consistently [watch the video 12:29].

Get more on: Anti-hypertensive medications | Cardiovascular disease complications | Type 1 diabetes | Type 2 diabetes

Editorial Board member Jay Shubrook and Advisory Board member Robert Chilton get together once more to discuss best practice tips for identifying and treating hypertension in patients with pre-existing diabetes [watch the video 12:17].

Get more on: Anti-hypertensive medications | Cardiovascular complications | Other videos in this series

In this editorial, Rishi Singh and colleagues provide their perspective on the future of proliferative diabetic retinopathy treatment following the completion of the CLARITY and Protocol S studies [read more].

Get more on: Retinopathy | Medications | Diabetic complications